trial summary · NCT07224763
Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD
EXTEND: A Prospective Study to Evaluate the Safety and Efficacy of GGTA1 KO Thymokidney XenoTransplantation in Patients With End-stage Renal Disease (ESRD)
Trial record from the TrialBase DB dataset, status RECRUITING, condition ESRD (End-Stage Renal Disease), sponsored by United Therapeutics. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
The purpose of this study is to evaluate the safety and efficacy of the GGTA1 KO Thymokidney in patients with end-stage renal disease (ESRD) who are either not eligible for conventional allogeneic kidney transplantation (Group 1) or are on an Organ Procurement and Transplantation Network (OPTN) kidney transplant waitlist, but are more likely to die or go untransplanted within 5 years than receive a kidney transplant (Group 2). The study consists of xenotransplantation followed by a 24-week Post-transplant Follow-up Period (Part A) to evaluate the efficacy and safety objectives followed by a Long-term Follow-up Period (Part B) to evaluate participant survival, GGTA1 KO Thymokidney survival, and screening for zoonotic infections. Part B will continue for the lifetime of the participant or for 52 weeks following nephrectomy, if required.
Source record: https://clinicaltrials.gov/study/NCT07224763
Facts
| registry id | NCT07224763 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | PHASE1/PHASE2 |
| study type | INTERVENTIONAL |
| lead condition | ESRD (End-Stage Renal Disease) |
| sponsor | United Therapeutics |
| sponsor class | INDUSTRY |
| enrollment | 50 |
| start date | 2026-11 |
| primary completion | 2029-11 |
| completion | not reported |
| results posted | not reported |
Conditions
- ESRD (End-Stage Renal Disease)
- Kidney Transplantation
- Xenotransplantation
Interventions
- GGTA1 KO Thymokidney
Countries
- United States
Intervention types: BIOLOGICAL
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.